Food Biodiversity and Human Health
Launched by HOSPICES CIVILS DE LYON · Mar 14, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Food Biodiversity and Human Health," is studying how changes in diet, particularly the introduction of certain cereals like einkorn, can affect the bacteria in our mouths. Researchers want to see if a healthier diet can help reduce harmful bacteria linked to periodontal disease and other chronic illnesses, such as cancer. The trial aims to explore the relationship between our oral health and what we eat, highlighting the importance of a diverse and nutritious diet that includes more plant-based proteins.
To participate in this study, you need to be between 20 and 60 years old, follow an omnivorous diet (eating both animal and plant foods), and be willing to attend at least one cooking workshop. You must also have a body mass index (BMI) above 18. However, some people can't join, including those with certain health conditions, allergies, or who are currently pregnant or breastfeeding. If you take part, you can expect to learn more about healthy eating while contributing to research that could improve oral and overall health for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Person between 20 and 60 years old
- • Person with an omnivorous diet
- • Person who has given free, informed, express written consent
- • Person affiliated to a French social security system
- • Person with a body mass greater than 18 kg/m²
- • Person able to attend at least 1 culinary workshop
- Exclusion Criteria:
- • Person with a smoking addiction
- • Person with a known food allergy/intolerance
- • Person unable to consume dairy or solid products (e.g. chocolate milk pudding, chocolate jelly)
- • Person participating in another study related to nutrition
- • Patients at high risk of infective endocarditis
- • Person with chronic pathologies
- • Person having taken antibiotic treatment during the month preceding the start of the study
- • Pregnant, parturient or breastfeeding woman
- • Minors
- • Persons deprived of liberty by a judicial or administrative decision
- • People receiving psychiatric care
- • Persons admitted to a health or social establishment for purposes other than research
- • Adults subject to a legal protection measure (guardianship, curatorship)
- • Persons not affiliated to a social security scheme or beneficiaries of a similar scheme
- • Person with fewer than 20 natural teeth
- • Person performing interdental hygiene and/or daily mouthwashes.
- • Person wearing orthodontic appliance
- • Person with periodontal disease (stage ≥ II periodontal lesions according to the Chicago 2017 classification (i.e. PD ≥ 4 mm, and/or CAL ≥ 4 mm) and/or generalized (\>30% of sites )), active caries or during dental care
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lyon, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported